Editorial Comment
Prevalence, Circumstances, Mechanisms, and Risk Stratification of Sudden Cardiac Death in Artificial Ventricular Pacing Seymour Furman, MD C ausation of death in patients with an implanted pacemaker is of continuing interest. The possibilities are numerous and include accident, diseases independent of pacing, and complications of pacing. However, the cause of death may be uncertain when a patient with an implanted pacemaker that is last known to be functioning normally and with no evidence for sudden pacemaker malfunction dies suddenly. No more than 2.5% of the pulse generators removed after the death of patients have been defective; only half of these may have been lethal (W. Irnich, personal communication). Only a small proportion of patients are truly pacemaker dependent and face the likelihood of sudden death or serious injury if the pacemaker were to fail suddenly or over a very brief time. Two pacemaker malfunctions are dangerous: Sudden no output failure (seen twice by this author during the past 6 months with neither patient seriously injured) and runaway, a rapid stimulation rate, perhaps several hundred beats per minute, are the most lethal of all malfunctions. Both can be detected after death, but sudden no output is uncommon, and for all practical purposes runaway no longer exists in modern pacemaker systems. An occasional Holter recording has demonstrated pacemaker system failure and patient death, but little evidence of device failure causing patient death has developed over the years. After a pacemaker is implanted, patients have been shown to live about as long and to die at about the same rate as a matched general population. Furthermore, the cause of death may be similar,1 especially after allowing for early mortality of the group in whom a pacemaker was implanted as an unsuccessful salvage procedure. The article by Zehender et a12 in this issue of Circulation attempts to deal with this most difficult issue. The authors did not find pacemaker malfunction as a cause of patient mortality, an im-The opinions expressed in this editorial comment are not necessarily those of the editors or of the American Heart Association.
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There is an important reemphasis of the linkage of tachyarrhythmia and cardiac pacing3'4 unassociated with activity.5 Indeed, 47% of sudden deaths not deemed to be a result of stroke occurred while the patient was sedentary, and only 25% of the deaths occurred during activity. A possible cause, competitive cardiac stimulation, emphasized in Zehender et al's Figure 3 , results from the inability of a pacemaker to sense all potential ventricular foci. The more multifocal the ventricular premature beats are, the more likely they occasionally will go unsensed. This may be particularly true in patients with severe myocardial disease that is associated with a high incidence of ventricular ectopy, where the depolarization vector of some foci will be sufficiently small relative to a fixed position electrode, either unipolar or bipolar, that they will not be sensed.6 This situation may be unavoidable, is not due to pacemaker malfunction, but apparently infrequently results in tachyarrhythmias according to this article. In Figure  3 , pacemaker function is normal and no repetitive firing follows competitive stimulation. It still is good practice, in a patient who demonstrates competition between pacer activity and one or more multifocal premature ventricular beats, to reprogram to maximum useful sensitivity to avoid competition. Uncontrolled spontaneous tachyarrhythmia with or without an implanted pacemaker is associated with high mortality. Figure 4 demonstrates a wholly spontaneous run of multifocal ventricular tachycardia with normal pacemaker inhibition by the rapid ventricular rate, demonstrating again normal pacemaker function and quite abnormal cardiac function. Figures 5A  and 5B are of an agonally sick heart. In each of the Holter tracings of an almost terminal event, pacemaker function is entirely normal, sensing all of the idioventricular foci and responding at the proper escape interval with a stimulus that captures the ventricle. The ventricular premature beats that preceded the stimulus and those that followed normal ventricular capture demonstrate extreme myocardial irritability, especially Figure 5B in which three premature beats are followed by a single normal paced beat associated with further ectopic beating and eventual deterioration to ventricular fibrillation, requiring electrical defibrillation.
An important omission from this article is a dis-cuSsion of the relation of pacing mode to the totality of existing options for bradycardia pacing. In this study, 94% of patients were paced in the unipolar single-chamber, ventricular-inhibited (VVI) mode. Of the total who died (suddenly, or not), 2% had dual chamber (DDD), and an additional 2% had AAI pacing. Currently, in the United States, one third of implanted pacemakers are dual chamber; in Germany, the figure is approximately 20-25%. In some institutions, the proportion of dual-chamber pacemakers may approach 0%; in others, 60%. The benefits of bipolar pacing are largely ignored, although electromyographic interference is proposed as a cause of sudden loss of pacing and possible sudden death. Bipolar pacing largely eliminates the possibility. Because the implant rates for Germany and the United States have been stable during the time that the patients in this series were studied, it must be concluded that this study is not representative of the most modern pacing practices.
Whether the addition of atrial synchrony (i.e., dual-chamber pacing) would have provided protection or ameliorated some of the enumerated causes of death is unknown. However, the virtual lack of dual-chamber pacing (DDD and VDD) is a critical element in data interpretation. Atrial fibrillation caused by ventricular pacing7 may be associated with right and left atrial thrombi and subsequent embolization producing some of the episodes of stroke and sudden death. 8 Much is made of competition between pacemaker stimuli and spontaneous events. The difficulty with these demonstrations is that competition exists only in Figure 3 , and there without complication. When a stimulus falls in diastole, (i.e., noncompetitively) and that stimulus produces a single pacemaker beat and then, as in Figures 4 and 5 , repetitive beating and even ventricular fibrillation, the myocardium is probably severely diseased. What is not known is whether these events occurred during some special circumstance of enhanced vulnerability such as in-hospital therapy of myocardial infarction (as might be suggested by the prompt defibrillation in Figure SB Figure 4 is not of pacemaker-induced ventricular tachycardia or an arrhythmia resulting from a competitive pacemaker stimulus or stimuli. It demonstrates the spontaneous onset (and spontaneous termination) of a ventricular tachycardia independent of a pacemaker stimulus. The same events occur in the patient whose data are shown in Figures SA and SB. Not one of the tachycardias or the episode of ventricular fibrillation ( Figure SB) results from competition between a spontaneous beat and a pacemaker stimulus. Multiple firing and ventricular fibrillation prompted by a competitive unipolar cathodal stimulus9 are uncommon. When the stimulus falls well in diastole of a preceding spontaneous beat and tachycardia results, an extremely deteriorated myocardium instead of pacemaker malfunction is present. Of Figures 3, 4 , and 5, only Figure 3 demonstrates any event that might be construed as pacemaker malfunction, and in that event, it is without consequence.
The issue of whether pacemaker malfunction or spontaneous ventricular arrhythmia caused patient death remains unanswered. The evidence for malfunction is slight, whereas that for sudden death caused by simultaneously existing cardiovascular disease is far more substantial. The data demonstrate intercurrent ventricular tachycardia or fibrillation as a significant cause of mortality.
Pacemaker-related ventricular arrhythmia and intercurrent causes of death require comparison of this group with a similar patient population in whom similar arrhythmias and incidence of sudden death and stroke might be found. At the average age of this population, it is not surprising that many died of stroke and died suddenly. Without a comparison group, it is difficult to propose that this population is unique. The more data on this topic, the more likely it is that the causes of death of those implanted with pacemakers are, if populations are matched, the same as those without implanted pacemakers. We might then be able to conclude that implantation of a cardiac pacemaker eliminates bradycardic mortality and, beyond early mortality, that implantees can return to a normal life expectancy, which is a happy conclusion indeed.
